- AU$8.58bn
- AU$8.60bn
- AU$2.35bn
Annual cashflow statement for Cochlear, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 14.4 | 30 | 29.7 | 31.4 | 28.4 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 377 | 362 | 389 | 238 | 368 |
| Capital Expenditures | -77.2 | -95.9 | -89.8 | -103 | -90.7 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -61.7 | -29.8 | -15.9 | -12.6 | -13.8 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -139 | -126 | -106 | -115 | -105 |
| Financing Cash Flow Items | — | — | -0.1 | 0.1 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -221 | -310 | -324 | -367 | -344 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 19.7 | -73.8 | -41.9 | -238 | -88.1 |